Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Charles River Laboratories International

Market Cap: US$7.4b

Charles River Laboratories International, Inc.

LakeShore Biopharma

Market Cap: US$33.0m

A biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer.

Alzamend Neuro

Market Cap: US$7.5m

A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.

Newron Pharmaceuticals

Market Cap: CHF 209.6m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Diagonal Bio

Market Cap: SEK 13.1m

Operates as a biotechnology company in Sweden.

cbdMD

Market Cap: US$6.0m

Produces and distributes various cannabidiol (CBD) products in the United States.

Maravai LifeSciences Holdings

Market Cap: US$694.6m

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

ALX Oncology Holdings

Market Cap: US$83.0m

A clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.

Enanta Pharmaceuticals

Market Cap: US$167.0m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

Christina Lake Cannabis

Market Cap: CA$9.9m

A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.

ImmuPharma

Market Cap: UK£52.7m

A biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom.

PolyPeptide Group

Market Cap: CHF 791.8m

Operates as a contract development and manufacturing company in Europe, the United States, and India.

Regencell Bioscience Holdings

Market Cap: US$7.2b

Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.

Cardiol Therapeutics

Market Cap: CA$126.4m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Legend Biotech

Market Cap: US$6.1b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Oncolytics Biotech

Market Cap: US$125.5m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

KalVista Pharmaceuticals

Market Cap: US$653.3m

A biopharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs.

Hemogenyx Pharmaceuticals

Market Cap: UK£67.8m

A clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer.

Geron

Market Cap: US$848.6m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Spruce Biosciences

Market Cap: US$4.7m

A biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.

Medigene

Market Cap: €1.0m

A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.

Guard Therapeutics International

Market Cap: SEK 453.8m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Apellis Pharmaceuticals

Market Cap: US$2.9b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

Urteste

Market Cap: zł65.5m

Engages in the research and development of diagnostic tests for cancers.

PharmaSGP Holding

Market Cap: €352.3m

Manufactures and sells over-the-counter drugs and other healthcare products in Germany.

Plus Therapeutics

Market Cap: US$40.1m

A clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.

Immunic

Market Cap: US$86.7m

A biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.

Avacta Group

Market Cap: UK£207.9m

Engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally.

MIRA Pharmaceuticals

Market Cap: US$25.7m

Operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.

Delivra Health Brands

Market Cap: CA$6.4m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

BriaCell Therapeutics

Market Cap: CA$25.2m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

Exagen

Market Cap: US$237.2m

Designs, develops, and commercializes various testing products under the AVISE brand in the United States.

NuCana

Market Cap: US$7.6m

A clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer.

Telo Genomics

Market Cap: CA$7.5m

A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada.